Insomnia Pharmacology
Overview
Authors
Affiliations
Insomnia is not only the most common sleep disorder in the population, it is a frequent complaint heard overall by primary care physicians and specialists alike. Given the high prevalence of this disorder, its tendency to persist, and the frequency with which patients complain of symptoms in practice, it is imperative to have an understanding of basic sleep-wake mechanisms and the evolving field of pharmacologic approaches to enhance sleep. Currently, pharmacologic approaches are among the most widely used therapies for insomnia. This article reviews sleep-wake mechanisms, the neuroanatomic targets for sleep and wake-promoting agents, and discusses currently used agents to promote sleep and investigational hypnotics.
Research progress in the prevention and treatment of insomnia with classical prescriptions.
Shi X, Chen L, Li W, Wang R Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024; 48(10):1494-1505.
PMID: 38432879 PMC: 10929891. DOI: 10.11817/j.issn.1672-7347.2023.230200.
Big data in sleep medicine: prospects and pitfalls in phenotyping.
Bianchi M, Russo K, Gabbidon H, Smith T, Goparaju B, Westover M Nat Sci Sleep. 2017; 9:11-29.
PMID: 28243157 PMC: 5317347. DOI: 10.2147/NSS.S130141.
Addressing sleep disturbances: an opportunity to prevent cardiometabolic disease?.
Grandner M Int Rev Psychiatry. 2014; 26(2):155-76.
PMID: 24892892 PMC: 4143456. DOI: 10.3109/09540261.2014.911148.
The options available in cognitive behavioral therapy to prevent chronification of insomnia.
Cronlein T, Zulley J EPMA J. 2012; 2(3):309-14.
PMID: 23199166 PMC: 3405393. DOI: 10.1007/s13167-011-0095-9.